Navigation Links
Improved prognosis for esophageal cancer
Date:5/25/2011

In recent years, the number of cases of adenocarcinoma of the esophagus (or gullet) has been on the rise. At the same time, however, new ways of treatment are improving the outlook for patients. In the current issue of Deutsches rzteblatt International (Dtsch Artzebl Int 2011; 108[18]: 313𔃇), Angelika Behrens and her working group report on innovations in diagnosis and treatment.

The main cause of this cancer is reflux of gastric acid from the stomach, with heartburn as the main symptom. Other risk factors are being male, being overweight, and having relatives with this disease.

Today we are able to discover and treat adenocarcinoma (Barrett's carcinoma) at an early stage. This has chiefly been made possible by the introduction of high-definition videoendoscopy and endosonography (endoscopic ultrasound). Locally restricted tumors can be resected endoscopically. For locally advanced Barrett's carcinoma, the standard treatment is surgery combined with chemotherapy. For esophageal cancer that has already metastasized, there are new approaches to therapy based at the molecular level. So-called molecular targeting uses antibodies or small molecules to alter signal transduction directly inside the tumor cell and thus inhibit growth. The authors also report on their experience of treating over 1000 patients with this cancer.


'/>"/>

Contact: Dr. Christian Ell
Christian.Ell@HSK-Wiesbaden.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Medicare improved Canadian doctors salaries: Queens University study
2. PSA Test Could Be Improved to Spot Prostate Cancer
3. Improved protocols for contrast agents eliminates new cases of nephrogenic systemic fibrosis
4. Human Factors/Ergonomics research leads to improved bunk bed safety standards
5. PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a
6. Outcomes improved by longer delays between heart attacks and elective surgeries
7. Research may lead to new and improved vaccines
8. Improved lesion detection with time-of-flight PET scans affirmed
9. Novel methods for improved breast cancer survival
10. Improved behavioral health needed to respond to rising number of suicides among US Armed Forces
11. Apica Cardiovascular receives $5.1 million investment for improved heart surgery system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Ohio (PRWEB) , ... December 09, 2016 , ... ... of miniature, folded, pharmaceutical inserts and outserts. As a means of expanding ... This addition will enable Flottman to individually code professional inserts (PIs) and patient ...
(Date:12/9/2016)... ... , ... Mediaplanet today announces distribution of the latest edition of “Transplants,” a ... as an organ donor for the 123,000 people in the United States who are ... up to 8 saves through organ donation and enhance many others through tissue donation, ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing ... wellness program, at their world headquarters of Omni La Costa Resort & Spa in ... anyone seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... -- RxWiki Inc., a digital health company that powers the ... of pharmacies through its Digital Pharmacist SaaS platform, today ... on Fire" Award in the Health and Life Sciences ... award as one of Austin,s fastest growing companies," said ... "Our platform gives independent retail pharmacies the digital tools ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
(Date:12/8/2016)... Australia Ophthalmic Lasers Market Outlook to 2022 Summary ... to 2022", provides key market data on the Australia ... of US dollars, volume (in units) and average prices ... and YAG Lasers. The report also provides company ... market segements, and global corporate-level profiles of the key ...
Breaking Medicine Technology: